tiprankstipranks
Assembly Biosciences (ASMB)
NASDAQ:ASMB
US Market
ASMB
Assembly Biosciences
RESEARCH TOOLSreports

Assembly Biosciences (ASMB) Financial Statements

Compare
581 Followers

Assembly Biosciences Financial Overview

Assembly Biosciences's market cap is currently $457.96M. The company's EPS TTM is $1.393; its P/E ratio is -62.28; Assembly Biosciences is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is $-0.77. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 72.30M$ 28.52M$ 7.16M$ 0.00$ 6.25M
Gross Profit$ 72.17M$ 28.52M$ -41.74M$ -69.08M$ 6.25M
Operating Income$ -12.12M$ -45.42M$ -64.65M$ -94.11M$ -132.69M
EBITDA$ -11.99M$ -45.29M$ -64.20M$ -92.52M$ -90.58M
Net Income$ -6.12M$ -40.18M$ -61.23M$ -93.09M$ -129.85M
Balance Sheet
Cash & Short-Term Investments$ 248.11M$ 112.08M$ 130.25M$ 91.61M$ 146.63M
Total Assets$ 257.59M$ 119.17M$ 136.82M$ 101.79M$ 191.06M
Total Debt$ 2.63M$ 3.09M$ 2.34M$ 3.46M$ 6.48M
Net Debt$ -55.82M$ -35.26M$ -17.50M$ -48.95M$ -39.15M
Total Liabilities$ 50.84M$ 85.81M$ 95.73M$ 19.13M$ 22.13M
Stockholders' Equity$ 206.75M$ 33.36M$ 41.10M$ 82.66M$ 168.93M
Cash Flow
Free Cash Flow$ -41.16M$ -51.15M$ 22.49M$ -84.56M$ -96.49M
Operating Cash Flow$ -41.09M$ -51.12M$ 22.74M$ -84.46M$ -93.40M
Investing Cash Flow$ -113.47M$ 40.17M$ -69.14M$ 90.64M$ 26.52M
Financing Cash Flow$ 174.67M$ 29.45M$ 13.82M$ 614.00K$ 53.06M
Currency in USD

Assembly Biosciences Earnings and Revenue History

Income Statement >

Assembly Biosciences Debt to Assets

Balance Sheet >

Assembly Biosciences Cash Flow

Cash Flow >

Assembly Biosciences Forecast EPS vs Actual EPS

Earnings >